Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization.
about
HITlights: a career perspective on heparin-induced thrombocytopeniaFondaparinux: does it cause HIT? Can it treat HIT?IgG-class anti-PF4/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics.Prospective multicentre cohort study of heparin-induced thrombocytopenia in acute ischaemic stroke patients.HIT paradigms and paradoxes.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery.Screening frequency, incidence and pattern of heparin-induced thrombocytopenia syndrome at a large tertiary institution.Effects of a Foot Pump on the Incidence of Deep Vein Thrombosis After Total Knee Arthroplasty in Patients Given Edoxaban: A Randomized Controlled StudySuperficial vein thrombosis.Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.Spontaneous heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages and pulmonary embolism after total knee arthroplasty.
P2860
Q26828351-FAAFB924-C5D2-4B60-830A-51727A8A263FQ33392864-47CE5542-D075-4FBB-A149-D37F2F93FD1BQ33393788-736A8387-C9A5-47A9-8EEB-7C1725E1A07CQ33395782-0D2FB115-3177-4B17-83AB-59B67726B032Q33396313-82705445-E342-4B24-9872-A6AD1B133612Q33399580-2F747169-0D88-4354-842E-0342B7A4F1B1Q33406904-7691A8AF-13DB-4F4F-8AB9-6281A857DD3FQ33428351-E0A61B69-F525-4EFC-84BC-1C36F98C84E3Q33431708-C6BDB94D-A327-479C-954B-245363ECF4AAQ36445007-DE7A0C00-1DF0-41D4-B086-98AF3B319F97Q43905870-41C7C2C5-3C2C-49FF-8E44-7A6BFDA7AC1AQ47654986-1435800C-4FC5-489A-A355-2C8148CD7DB0Q53754886-02F8CD7D-1D73-4153-8E69-218A44C2EC2F
P2860
Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Anti-PF4/heparin antibody form ...... y-based model of immunization.
@ast
Anti-PF4/heparin antibody form ...... y-based model of immunization.
@en
type
label
Anti-PF4/heparin antibody form ...... y-based model of immunization.
@ast
Anti-PF4/heparin antibody form ...... y-based model of immunization.
@en
prefLabel
Anti-PF4/heparin antibody form ...... y-based model of immunization.
@ast
Anti-PF4/heparin antibody form ...... y-based model of immunization.
@en
P2093
P2860
P1476
Anti-PF4/heparin antibody form ...... y-based model of immunization.
@en
P2093
A Greinacher
V J Marder
P2860
P304
P356
10.1111/J.1538-7836.2009.03735.X
P577
2009-12-24T00:00:00Z